HGF and renal cell carcinoma: This review focuses on the cell-surface pro-HGF activation system in urological cancers, including prostate cancer (PC), renal cell carcinoma (RCC), and urothelial carcinoma (UC) of bladder, and summarizes its significance in the progression of cancer.